← FDA Drug Approvals (Drugs@FDA)

CISPLATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2017-03-17

Drug application

FDA Application #

ANDA207323

Application type

Abbreviated New Drug Application (Generic)

Brand name

CISPLATIN

Generic name

CISPLATIN

Active ingredients

CISPLATIN

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

GLAND

Manufacturer

Sagent Pharmaceuticals

First approval

2017-03-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown